TransPerfect Life Sciences
TransPerfect Life Sciences is the life sciences division of TransPerfect, providing AI-enabled translation, localization, and clinical trial technology (GlobalLink TMS, Trial Interactive eClinical platform) to 1,000+ pharmaceutical, biotech, medical device, and CRO organizations worldwide.
- Company typePrivate
- Founded-
- Headquarters—
- Headcount101–250
- GTM typeB2B
- OfferingServices
What TransPerfect Life Sciences does
TransPerfect Life Sciences is a specialized division of TransPerfect, a privately held global language services and technology firm, providing AI-enabled translation, localization, and clinical trial technology solutions to more than 1,000 life sciences organizations worldwide. The company serves large and mid-tier pharmaceutical companies (including Pfizer, Bristol-Myers Squibb, Sanofi, Merck, AstraZeneca, Bayer, and Novartis), biotechnology firms, medical device manufacturers, contract research organizations, and institutional review boards, with a vertically focused go-to-market delivered through enterprise field sales and consultative account management.
The product portfolio is anchored by two platform assets: GlobalLink, a translation management system with adjacent component content management (CCMS) and proprietary AI portal for real-time translation, and Trial Interactive, an eClinical platform offering eTMF, CTMS, document management, and remote monitoring. Supporting modules address specific workflow needs, including TransPerfect Automate (AI-powered eTMF), XCompare (COA migration), GlobalLink Strings (app localization), GlobalLink Now (customized generative AI access), OneLink (patient recruitment), and Transcend (corporate learning). The company maintains certified integrations with Veeva Vault RIM and Adobe Experience Cloud, and operates a separate AI data annotation service branded DataForce. Service offerings include regulatory submissions, COA/eCOA linguistic validation, pharmacovigilance, medical writing, IMP labeling, medical device MDR/IVDR compliance, patient engagement, and call center support.
Revenue is generated through a hybrid model: SaaS subscriptions for technology platforms (GlobalLink, Trial Interactive), project-based translation and language services priced per word or per page, regulatory and consulting services, and managed clinical operations engagements. Pricing is quote-based and customized per client. The company is headquartered in New York with operations in the United States and United Kingdom, and serves a global customer base leveraging the parent's worldwide delivery infrastructure. The division competes against pure-play language service providers, specialized clinical technology vendors, and in-house pharma localization teams.
TransPerfect Life Sciences firmographics
Firmographics- Name
- TransPerfect Life Sciences
- Legal name
- TransPerfect Life Sciences
- Website
- https://lifesciences.transperfect.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- TransPerfect Life Sciences is the life sciences division of TransPerfect, providing AI-enabled translation, localization, and clinical trial technology (GlobalLink TMS, Trial Interactive eClinical platform) to 1,000+ pharmaceutical, biotech, medical device, and CRO organizations worldwide.
- Ownership category
- akta.pro rank
TransPerfect Life Sciences industry classification
Industry- Product category
- Life Sciences Translation and Clinical Trial Technology Services
- NAICS
- Software Publishers (51321), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)
Keywords
TransPerfect Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Translation and Language Services: Provides translation, localization, and language solutions for clinical trial documentation, regulatory submissions, medical devices, and commercial content. Revenue generated through project-based pricing and per-word/per-page rates.
- Technology Platform Subscriptions: SaaS subscriptions for GlobalLink TMS, Trial Interactive eClinical Platform, and other technology solutions. Typically annual contracts with per-user or volume-based pricing.
- Regulatory and Consulting Services: Medical writing, regulatory submissions consulting, pharmacovigilance services, and compliance advisory for life sciences organizations.
- Clinical Operations Support: eCOA solutions, TMF services, call center support, patient engagement, and clinical trial management services.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
TransPerfect Life Sciences product offering
Product offeringCore offering
TransPerfect Life Sciences provides AI-enabled translation, localization, and clinical trial technology solutions to global life sciences organizations. Its offering combines proprietary technology platforms (GlobalLink TMS, Trial Interactive eClinical Platform, DataForce AI, GlobalLink CCMS) with specialized services spanning regulatory submissions, pharmacovigilance, COA/eCOA translations, medical writing, medical device compliance (MDR/IVDR), IMP labeling, patient engagement, and call center support. The portfolio is organized across Research & Development, Commercialization, and Corporate segments, serving pharmaceutical, biotech, medical device, CRO, and IRB customers in 1,000+ organizations worldwide.
Product overview
TransPerfect Life Sciences offers a comprehensive suite of technology-enabled solutions for global life sciences organizations spanning pharmaceutical, biotech, medical device, CRO, and IRB sectors. The portfolio consists of core technology platforms (GlobalLink TMS, Trial Interactive eClinical Platform, DataForce AI, GlobalLink CCMS) that integrate with enterprise systems like Veeva Vault RIM and Adobe Experience Cloud, supported by specialized modules (TransPerfect Automate, XCompare, GlobalLink Strings, GlobalLink Now, OneLink, Transcend, Applanga) for specific workflow needs. Services include regulatory submissions, translation and language solutions, COA/eCOA solutions, pharmacovigilance, TMF solutions, medical writing, medical device solutions (MDR/IVDR), IMP labeling, patient engagement, call center support, and digital marketing—organized across three segments: Research & Development, Commercialization, and Corporate.
Differentiator
Problem solved
Functional benefit
Products and services
- GlobalLink Translation management system (TMS) that automates translation workflows, manages multilingual content, and integrates with enterprise platforms like Adobe Experience Cloud and Veeva Vault RIM for life sciences organizations.
- Trial Interactive eClinical platform providing eTMF, TMF services, CTMS, document management, and remote monitoring solutions for sponsors, CROs, and clinical research sites worldwide.
- DataForce AI data annotation service providing human-in-the-loop annotation for machine learning models, including image annotation for healthcare AI, adverse event detection, and NLP tasks.
- GlobalLink CCMS Component Content Management System enabling structured content authoring, content reuse up to 50%, omnichannel delivery, and streamlined review and approval processes.
- Translation and Language Solutions Document translation services combining technology and expert linguist support to manage multilingual challenges across life sciences documentation including clinical, regulatory, and commercial content.
- Regulatory Submissions and Translations Regulatory submission solutions including eCTD preparation, XML product monograph filing, and compliance with Health Canada, FDA, and EU CTR requirements.
- Pharmacovigilance and Safety Solutions Drug safety monitoring services including adverse event detection, literature monitoring, safety database reporting, case triaging, and AI-powered pharmacovigilance automation.
- TMF Solutions Trial Master File management, inspection readiness, TMF services, and electronic TMF (eTMF) solutions for clinical trial documentation.
- eClinical Solutions Comprehensive eClinical platform including CTMS, site portals, remote monitoring, and investigator collaboration tools via Trial Interactive.
- Medical Writing Professional medical writing services including informed consent forms, clinical study reports, protocol authoring, and regulatory documentation.
- Medical Device Solutions
Quantifiable outcome
- 33% cost reduction and 40% less PM oversight for global COA programs
- +4 more outcomes
Companies that use TransPerfect Life Sciences
Customer profileNamed customers32 records
Segments5 records
Ideal customer profiles4 records
TransPerfect Life Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability10 records
Feature9 records
TransPerfect Life Sciences partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- VeevacoreIntegration between TransPerfect's GlobalLink CCMS and Veeva Vault RIM enables life sciences companies to automatically generate compliant XML files for regulatory submissions, align with Health Canada's structured templates, collaborate across global teams, and maintain secure role-based access for content integrity and control.
- AdobecoreGlobalLink Connect integration with Adobe Experience Cloud enables pharmaceutical companies to manage translation processes within their digital asset management system, eliminating external workflow layers and enabling smoother translation and approval flows for multilingual content.
- Genmab A/SminorCollaboration featuring Genmab's Director of Global Clinical Drug Supply as speaker in IMP labeling webinar, sharing firsthand experiences in centralizing IMP labeling workflows.
- Jazz PharmaceuticalsminorPartnership featuring Jazz Pharmaceuticals' Senior Director of Clinical Trial Supplies as speaker on IMP labeling workflows, sharing practical operating models for label content creation through translation, regulatory alignment, and distribution.
- Straumann GroupminorCollaboration in corporate academy webinar featuring Straumann Group's VP of Global Strategic Projects Medical Education discussing challenges of scaling education globally.
- IvoclarminorPartnership featuring Ivoclar's Director of Global Academy discussing what goes wrong when trying to scale education globally.
- Edwards LifesciencesminorCollaboration featuring Edwards Lifesciences' AI & Digital L&D Manager in academy scalability webinar discussing AI in learning and development.
- VvardisminorPartnership featuring Vvardis' VP of Training and Clinical Education in corporate academy discussion on scaling education globally.
- QserveminorCollaboration featuring Qserve's VP of Regulatory Compliance in fireside chat on MDR translation review process for SSCPs.
- Partner4BetterminorCollaboration with Pfizer on Global Learning Program (Partner4Better) delivering educational content to global audiences in diverse languages.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
TransPerfect Life Sciences competitors and assessment
Company assessmentDirect peers
- RWS Group: RWS is one of the world's largest language services providers with a dedicated life sciences division (including the SDL acquisition) offering regulatory, clinical, and medical translation, localization, and content management — directly comparable to TransPerfect Life Sciences' translation and language services portfolio.
- Signant Health: Signant Health specializes in eCOA, patient engagement, and clinical outcome assessment solutions — directly competing with TransPerfect's COA/eCOA, XCompare, and Trial Interactive offerings for clinical outcome data capture and management.
- Welocalize: Welocalize is a global translation and localization company with a strong life sciences vertical serving pharma, biotech, and medical device clients — competing directly with TransPerfect on regulatory, clinical, and commercial translation engagements.
- CSOFT International: CSOFT is a translation and localization company with dedicated life sciences expertise in regulatory, clinical, and medical translation — a focused direct competitor to TransPerfect's Translation & Language Solutions for regulated content.
- Lionbridge Life Sciences: Lionbridge's Life Sciences practice provides clinical trial translation, medical device localization, and regulatory content services for pharma and biotech — a head-to-head competitor to TransPerfect's Translation & Language Solutions and COA/eCOA offerings.
- SDL (now part of RWS): SDL's language services and Trados translation technology platform, now part of RWS, historically competed with TransPerfect GlobalLink for TMS deployments and translation services within life sciences.
Broad incumbents
- Veeva Systems: Veeva's Vault CTMS/eTMF/RIM suite is the dominant sponsor-side eClinical and regulatory platform; directly comparable to Trial Interactive for clinical trial document management and competes via Veeva Vault RIM against GlobalLink for regulatory submission workflows.
- Medidata Solutions (Dassault Systèmes): Medidata's Rave CTMS, eTMF, and RTSM platforms serve the same sponsor and CRO customers as Trial Interactive; both target global clinical trial operations with integrated document, site, and patient data management.
- IQVIA: IQVIA is the largest CRO and a major provider of clinical technology (including its own CTMS and eCOA platforms); as both a customer and a competitive threat, IQVIA overlaps with TransPerfect on trial technology, eClinical services, and language-enabled clinical operations.
- Oracle Health Sciences (Clinical One): Oracle Clinical One and its legacy eClinical suite compete with Trial Interactive for unified clinical trial management, and Oracle's broader life sciences portfolio touches regulatory and pharmacovigilance workflows analogous to GlobalLink.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
TransPerfect Life Sciences social profiles
Digital presenceTransPerfect Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
TransPerfect Life Sciences leadership team
Management profileNumber of profiles
Profiles6 records
TransPerfect Life Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TransPerfect Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TransPerfect Life Sciences
What does TransPerfect Life Sciences do?
TransPerfect Life Sciences provides AI-enabled translation, localization, and clinical trial technology solutions to global life sciences organizations. Its offering combines proprietary technology platforms (GlobalLink TMS, Trial Interactive eClinical Platform, DataForce AI, GlobalLink CCMS) with specialized services spanning regulatory submissions, pharmacovigilance, COA/eCOA translations, medical writing, medical device compliance (MDR/IVDR), IMP labeling, patient engagement, and call center support. The portfolio is organized across Research & Development, Commercialization, and Corporate segments, serving pharmaceutical, biotech, medical device, CRO, and IRB customers in 1,000+ organizations worldwide.
Is TransPerfect Life Sciences a public or private company?
TransPerfect Life Sciences is a private company. It is classified as corporate owned and is currently operating.
When was TransPerfect Life Sciences founded?
TransPerfect Life Sciences was founded in -1. It employs 101 to 250 people.
How does TransPerfect Life Sciences make money?
Four revenue lines are on record. Translation and Language Services are the primary driver. The others are technology Platform Subscriptions, regulatory and Consulting Services and clinical Operations Support.
Who are TransPerfect Life Sciences's main competitors?
Direct peers on record are RWS Group, Signant Health, Welocalize, CSOFT International, Lionbridge Life Sciences and SDL (now part of RWS). Broad incumbents are Veeva Systems, Medidata Solutions (Dassault Systèmes), IQVIA and Oracle Health Sciences (Clinical One).
Does TransPerfect Life Sciences have an API?
Yes. Trial Interactive offers an Open API that enables connectivity with other clinical trial systems such as Electronic Data Capture (EDC) and Interactive Voice Response (IVR) systems. The API allows sponsors and CROs to integrate with the CTMS platform for data exchange and workflow automation.
What industry is TransPerfect Life Sciences in?
TransPerfect Life Sciences's product category is Life Sciences Translation and Clinical Trial Technology Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAJAL, Regulatory Information Management (RIM) & Submission Publishing Software. Its NAICS code is 51321 and its SIC code is 7372.